Rajeev Dadoo's most recent trade in ARS Pharmaceuticals Inc was a trade of 30,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 25, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ARS Pharmaceuticals Inc | Rajeev Dadoo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Jun 2025 | 30,000 | 30,000 | - | - | Stock Option (right to buy) | |
| ARS Pharmaceuticals Inc | Rajeev Dadoo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2024 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| ARS Pharmaceuticals Inc | Rajeev Dadoo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2023 | 40,000 | 40,000 | - | - | Stock Option (right to buy) | |
| ARS Pharmaceuticals Inc | Rajeev Dadoo | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Nov 2022 | 3,009,677 | 3,009,677 | - | - | Common Stock |